Related Experiment Video
Updated: Oct 17, 2025

Hemodynamic Precision in the Neonatal Intensive Care Unit using Targeted Neonatal Echocardiography
Published on: January 27, 2023
High alanine aminotransaminase associated with daptomycin use in a premature infant
Suzan Suhail Asfour1, Fahad Aljobair2, Adli Abdelrahim3
1Clinical Pharmacy Department, Pharmacy Department, King Saud Medical City, Riyadh, Saudi Arabia.
Insights
Daptomycin, an antibiotic for gram-positive infections, may cause liver damage in premature infants. A case study revealed elevated liver enzymes and coagulation issues shortly after daptomycin administration in a neonate.
Area of Science:
- Pharmacology
- Neonatal Medicine
- Infectious Diseases
Background:
- Daptomycin is a lipopeptide antibiotic effective against gram-positive bacteria.
- Its use in premature infants is established for various infections.
Purpose of the Study:
- To report a case of potential hepatotoxicity in a premature infant receiving daptomycin.
- To highlight a previously unrecognized adverse drug effect.
Main Methods:
- Case report of a premature infant treated with daptomycin.
- Monitoring of liver function tests (alanine aminotransaminase) and coagulation parameters (prothrombin time, international normalised ratio).
Main Results:
- The infant developed elevated alanine aminotransaminase, prolonged prothrombin time, and increased international normalised ratio.
- These changes occurred rapidly following daptomycin administration.
Conclusions:
- Daptomycin may be associated with hepatotoxicity and coagulopathy in premature infants.
- Close monitoring for liver function and coagulation is recommended in this population.
Abstract:
Daptomycin is a cyclic lipopeptide antibiotic, a fermented product derived from Streptomyces roseosporus that is active against gram-positive bacteria. We report on a premature infant who developed hepatotoxicity as an adverse drug reaction after the administration of daptomycin 6 mg per kg per dose every 12 h. The patient had an unexpectedly sharp rise of alanine aminotransaminase, prothrombin time and international normalised ratio on the second day following daptomycin administration. This case illustrates a previously unrecognised adverse drug effect associated with daptomycin use in infants.
Related Concept Videos
Estimation of k and VD of Aminoglycosides
Drug Accumulation During Multiple Dosing: Intermittent IV Infusions
Pharmacokinetics in Pediatric Patients: Drug Excretion
Determination of Multiple Dosing Parameters: Steady-State, Minimum and Maximum Concentrations

